Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Non-squamous NSCLC × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 177 Breast Neoplasms 122 Prostatic Neoplasms 66 Neoplasms 56 Neoplasm Metastasis 46 Lung Neoplasms 45 Stomach Neoplasms 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 17 Squamous Cell Carcinoma of Head and Neck 16 Ovarian Neoplasms 14 Advanced Solid Tumors 13 Recurrence 12 Urinary Bladder Neoplasms 11 Head and Neck Neoplasms 10 Carcinoma, Squamous Cell 10 Melanoma 9 Colorectal Neoplasms 9 Esophageal Neoplasms 8 Carcinoma, Renal Cell 8 Solid Tumor 7 Esophageal Squamous Cell Carcinoma 7 Endometrial Neoplasms 7 Carcinoma, Transitional Cell 7 Carcinoma 7 Triple Negative Breast Neoplasms 6 Prostatic Neoplasms, Castration-Resistant 6 Pancreatic Neoplasms 6 Neutropenia 6 HER2-positive Breast Cancer 6 Solid Tumors 5

Interventions

pyrotinib 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447118 2025-12-19

PYRAMID-1

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed

Non-squamous NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡